The PE Ratio as of December 2024 (TTM) for Imunon, Inc. (IMNN) is -0.43

According to Imunon, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.43. This represents a change of -7.84% compared to the average of -0.47 of the last 4 quarters.

Imunon, Inc. (IMNN) Historical PE Ratio (quarterly & annually)

How has IMNN PE Ratio performed in the past?

The mean historical PE Ratio of Imunon, Inc. over the last ten years is -1.32. The current -0.43 PE Ratio has changed 3.17% with respect to the historical average. Over the past ten years (40 quarters), IMNN's PE Ratio was at its highest in in the December 2018 quarter at 1.23. The PE Ratio was at its lowest in in the June 2020 quarter at -5.20.

Imunon, Inc. (IMNN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Imunon, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Imunon, Inc. (IMNN) Average PE Ratio

How has IMNN PE Ratio performed in the past?

The current PE Ratio of Imunon, Inc. (IMNN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Imunon, Inc. (IMNN) PE Ratio vs. Peers

How is IMNN’s PE Ratio compared to its peers?

Imunon, Inc.’s PE Ratio is greater than Exicure, Inc. (-8.14), less than Cyclacel Pharmaceuticals, Inc. (-0.06), less than Histogen Inc. (-0.01), greater than DiaMedica Therapeutics Inc. (-10.36), greater than Neoleukin Therapeutics, Inc. (-5.86), less than Senti Biosciences, Inc. (-0.27), greater than Hillstream BioPharma, Inc. (-0.99), greater than SAB Biotherapeutics, Inc. (-0.83), less than Quoin Pharmaceuticals, Ltd. (-0.28), greater than SAB Biotherapeutics, Inc. (-0.83), less than Cingulate Inc. (-0.00), less than Bellicum Pharmaceuticals, Inc. (-0.28), greater than Lisata Therapeutics, Inc. (-1.24), greater than Lixte Biotechnology Holdings, Inc. (-1.18), less than Kineta, Inc. (-0.36), less than Theriva Biologics, Inc. (-0.07), greater than Lumos Pharma, Inc. (-1.04), greater than Diffusion Pharmaceuticals Inc. (-1.62), greater than Avalo Therapeutics, Inc. (-9.00), greater than Catalyst Biosciences, Inc. (-28.21),

Build a custom stock screener for Imunon, Inc. (IMNN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Imunon, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Imunon, Inc. (IMNN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Imunon, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.